1. Search Result
Search Result
Results for "

5-HT<sub>1</sub>

" in MedChemExpress (MCE) Product Catalog:

5647

Inhibitors & Agonists

8

Screening Libraries

3

Fluorescent Dye

13

Biochemical Assay Reagents

24

Peptides

2

MCE Kits

2

Inhibitory Antibodies

73

Natural
Products

13

Recombinant Proteins

4279

Isotope-Labeled Compounds

17

Antibodies

21

Click Chemistry

3

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B1473A
    Serotonin
    15+ Cited Publications

    5-Hydroxytryptamine; 5-HT

    5-HT Receptor COMT Endogenous Metabolite Neurological Disease
    Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM.
    Serotonin
  • HY-B1473
    Serotonin hydrochloride
    15+ Cited Publications

    5-Hydroxytryptamine hydrochloride; 5-HT hydrochloride

    5-HT Receptor COMT Endogenous Metabolite Neurological Disease
    Serotonin (5-Hydroxytryptamine) hydrochloride is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin hydrochloride is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM.
    Serotonin hydrochloride
  • HY-B1473AS

    5-Hydroxytryptamine-d<sub>4sub>; 5-HT-d<sub>4sub>

    Isotope-Labeled Compounds 5-HT Receptor COMT Endogenous Metabolite Neurological Disease
    Serotonin-d4 is deuterium labeled Serotonin. Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM.
    Serotonin-d4
  • HY-B1473S

    5-Hydroxytryptamine-d<sub>4sub> hydrochloride; 5-HT-d<sub>4sub> hydrochloride

    Isotope-Labeled Compounds 5-HT Receptor Endogenous Metabolite COMT Others
    Serotonin-d4 (5-Hydroxytryptamine-d4) hydrochloride is the deuterium labeled Serotonin (hydrochloride) (HY-B1473) [1]. Serotonin (5-Hydroxytryptamine) hydrochloride is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin hydrochloride is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM .
    Serotonin-d4 hydrochloride
  • HY-RS13999

    Small Interfering RNA (siRNA) Others

    SUB1 Human Pre-designed siRNA Set A contains three designed siRNAs for SUB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    SUB1 Human Pre-designed siRNA Set A
    SUB1 Human Pre-designed siRNA Set A
  • HY-RS18793

    Small Interfering RNA (siRNA) Others

    Sub1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sub1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Sub1 Mouse Pre-designed siRNA Set A
    Sub1 Mouse Pre-designed siRNA Set A
  • HY-RS25282

    Small Interfering RNA (siRNA) Others

    Sub1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sub1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Sub1 Rat Pre-designed siRNA Set A
    Sub1 Rat Pre-designed siRNA Set A
  • HY-169611

    5-Hydroxytryptamine maleate; 5-HT maleate

    5-HT Receptor COMT Neurological Disease
    Serotonin hydrogen maleate is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin hydrogen maleate is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM [1] .
    Serotonin maleate
  • HY-P10215

    Parasite Infection
    Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2 (compound 40) is a potent Plasmodium subtilisin-like protease 1 (SUB1) inhibitor. SUB1-IN-1 shows IC50 values of 12 nM and 10 nM against P. vivax and P. falciparum SUB1 (Pv- and PfSUB1), respectively [1].
    Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2
  • HY-124086

    5-HT Receptor Neurological Disease
    BHQ-O-5HT is a light-activated caged 5-HT protected by a BHQ group. When exposed to light at 365 or 740 nm, BHQ-O-5HT releases 5-HT through 1 or 2 photon excitation, respectively. BHQ-O-5HT can be manipulated in space and time to explore the role of 5-HT in regulating mood, appetite, memory, learning, and other cognitive functions [1].
    BHQ-O-5HT
  • HY-B1473S2

    5-Hydroxytryptamine-13C,D<sub>4sub>; 5-HT-13C,D<sub>4sub>

    Isotope-Labeled Compounds 5-HT Receptor COMT Endogenous Metabolite Neurological Disease
    Serotonin- 13C,D4 (5-Hydroxytryptamine-13C,D4) is a 13C- and deuterated labeled Serotonin (HY-B1473A). Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM [1] .
    Serotonin-13C,D4
  • HY-B1473S1

    5-Hydroxytryptamine-13C<sub>2sub>,15N hydrochloride; 5-HT-13C<sub>2sub>,15N hydrochloride

    Isotope-Labeled Compounds 5-HT Receptor COMT Endogenous Metabolite Neurological Disease
    Serotonin- 13C2, 15N hydrochloride is the 13C- and 15N-labeled Serotonin hydrochloride (HY-B1473). Serotonin hydrochloride is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin hydrochloride is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM [1] .
    Serotonin-13C2,15N hydrochloride
  • HY-B0352S

    Org3770 d<sub>3sub>; 6-Azamianserin d<sub>3sub>

    5-HT Receptor Neurological Disease
    Mirtazapine-d3 is a deuterium labeled Mirtazapine. Mirtazapine is a 5-HT receptor inhibitor. Mirtazapine is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent by blocking 5-HT2 and 5-HT3 receptors [1].
    Mirtazapine-d3
  • HY-B1287S

    (±)-Citalopram hydrobromide-d<sub>3sub>; Lu 10-171-d<sub>3sub>

    Isotope-Labeled Compounds Serotonin Transporter Autophagy Neurological Disease Cancer
    Citalopram-d3 ((±)-Citalopram-d3) hydrobromide is deuterium labeled Citalopram (hydrobromide). Citalopram hydrobromide is a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide inhibits 5-HT uptake into synaptosomes with an IC50 of 1.8 nM. Citalopram hydrobromideinhibits the 5-HT uptake in rabbit blood platelets with an IC50 of 14 nM. Antidepressant effect [1] .
    Citalopram-d3 hydrobromide
  • HY-146227

    Topoisomerase Apoptosis Cancer
    DNA topoisomerase II inhibitor 1 (compound 8ed) is a potent DNA topoisomerase II inhibitor. DNA topoisomerase II inhibitor 1 shows anti-proliferative activity. DNA topoisomerase II inhibitor 1 induces apoptosis and cell cycle arrest at sub G1 phase [1].
    DNA topoisomerase II inhibitor 1
  • HY-W615853

    5-HT Receptor Others
    5-HT1A modulator 4 (Compound 1) is a ligand of 5-HT receptors. 5-HT1A modulator 4 has Ki values of 2.18 μM and 19.7 μM for 5-HT1A and 5-HT2A, respectively [1].
    5-HT1A modulator 4
  • HY-176216

    5-HT Receptor Neurological Disease
    5-HT2C agonist-5 (Compound 3A) is a 5-HT2C agonist (EC50: <1 nM). 5-HT2C agonist-5 can be used for research of brain disorders [1].
    5-HT2C agonist-5
  • HY-B0457S1

    Chlorimipramine-d<sub>6sub> hydrochloride; G-34586-d<sub>6sub> hydrochloride; NSC-169865-d<sub>6sub> hydrochloride

    Isotope-Labeled Compounds Serotonin Transporter Neurological Disease
    Clomipramine-d6 (hydrochloride) is the deuterium labeled Clomipramine hydrochloride. Clomipramine (Chlorimipramine) hydrochloride is a potent 5-HT reuptake blocker with the IC50 value of 1.5 nM. Clomipramine hydrochloride is a tricyclic antidepressant that can be used for the research of depression and obsessive compulsive disorder (OCD) [1].
    Clomipramine-d6 hydrochloride
  • HY-160656

    5-HT Receptor Neurological Disease
    5-HT/NA Reuptake inhibitor-1 (compound 9) is a selective dual 5-HT and NA reuptake inhibitor with IC50 of 660 nM and 70 nM respectively. . 5-HT/NA Reuptake inhibitor-1 has good in vitro human metabolic stability, hERG selectivity and passive membrane permeability [1].
    5-HT/NA Reuptake inhibitor-1
  • HY-14542S

    CP-88059 d<sub>8sub>

    Isotope-Labeled Compounds 5-HT Receptor Dopamine Receptor Neurological Disease
    Ziprasidone-d88 is deuterium labeled Ziprasidone, which is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects of antipsychotic activity.
    Ziprasidone-d8
  • HY-W681014

    5-HT Receptor Dopamine Receptor Neurological Disease
    5-Fluoro-α-methyltryptamine hydrochloride may cause an increase in intracellular levels of 5-HT followed by an increase in 5-HT release. 5-Fluoro-α-methyltryptamine hydrochloride exhibits EC50 values of 37 nM, 14 nM, 78 nM and 8.47 nM for DA, 5HT, NE and 5-HT2A, respectively [1] .
    5-Fluoro-α-methyltryptamine hydrochloride
  • HY-173044

    5-HT Receptor Dopamine Receptor Neurological Disease
    5-HT1AR/5-HT6R ligand-1 (Compound PP13) is the ligand for 5-HT receptor that exhibits good affinity to 5-HT1AR, 5-HT6R and 5-HT7R (Ki of 19, 69 and 198 nM, respectively), thereby inhibiting the cAMP production in HEK293 cell with EC50 of 1535, 488 and 53 nM, respectively. 5-HT1AR/5-HT6R ligand-1 exhibits anti-proliferative activity against a variety of cancer cells (IC50 for 1321N1, U87MG, MCF7, and AsPC-1 is 9.6, 13.6, 19.3 and 14.6 μM, respectively). 5-HT1AR/5-HT6R ligand-1 also exhibits antagonist activity for dopamine receptor D2R with Ki of 1903 nM [1].
    5-HT1AR/5-HT6R ligand-1
  • HY-B1396S

    BMY-13754-d<sub>6sub>; MJ-13754-1-d<sub>6sub>

    Isotope-Labeled Compounds 5-HT Receptor Adrenergic Receptor Neurological Disease Endocrinology
    Nefazodone-d6 (hydrochloride) is the deuterium labeled Nefazodone hydrochloride. Nefazodone hydrochloride (BMY-13754) is a potent and selective 5HT2A (Ki=5.8 nM) antagonist with moderate inhibition of 5-HT and noradrenaline uptake (IC50 of 290 and 300 nM, respectively). Nefazodone hydrochloride is a phenylpiperazine antidepressant with less alpha-adrenergic blocking activity [1] .
    Nefazodone-d6 hydrochloride
  • HY-B1396S1

    BMY-13754-d<sub>6sub> dihydrochloride; MJ-13754-1-d<sub>6sub> dihydrochloride

    Isotope-Labeled Compounds 5-HT Receptor Adrenergic Receptor Neurological Disease Endocrinology
    Nefazodone-d6 (dihydrochloride) is deuterium labeled Nefazodone (hydrochloride). Nefazodone hydrochloride (BMY-13754) is a potent and selective 5HT2A (Ki=5.8 nM) antagonist with moderate inhibition of 5-HT and noradrenaline uptake (IC50 of 290 and 300 nM, respectively). Nefazodone hydrochloride is a phenylpiperazine antidepressant with less alpha-adrenergic blocking activity [1] .
    Nefazodone-d6 dihydrochloride
  • HY-B1658BS

    (R)-Frovatriptan-d<sub>3sub> succinate; SB 209509-d<sub>3sub> succinate; VML 251-d<sub>3sub> succinate

    Isotope-Labeled Compounds 5-HT Receptor Neurological Disease
    Frovatriptan-d3 (succinate) is deuterium labeled Frovatriptan (succinate). Frovatriptan succinate ((R)-Frovatriptan succinate) is a potent, high affinity, selective and orally active 5-HT1B (pK50 of 8.2) and 5-HT1D receptor agonist. Frovatriptan succinate exhibits >10-fold selectivity for 5-HT1B and 5-HT1D over 5-HT1A, 5-HT1F, and 5-HT7 and >1000-fold selectivity over other 5-HT, dopamine, histamine H1, and α1-adrenoceptor. Frovatriptan succinate has the potential for migraine research [1] .
    Frovatriptan-d3 succinate
  • HY-113008AS

    (Z)-Urocanic acid-13C<sub>3sub>; cis-UCA-13C<sub>3sub>

    Isotope-Labeled Compounds 5-HT Receptor Inflammation/Immunology
    cis-Urocanic acid- 13C3 is the 13C-labeled cis-Urocanic acid. cis-Urocanic acid is a 5-HT2A receptor agonist. cis-Urocanic acid binds to 5-HT receptor with relatively high affinity (Kd=4.6 nM). cis-Urocanic acid is an immune modulator that induces immunosuppression by binding to the 5-HT2A receptor [1].
    cis-Urocanic acid-13C3
  • HY-16567S

    Org 5222-13C,d<sub>3sub> hydrochloride

    Isotope-Labeled Compounds 5-HT Receptor Dopamine Receptor Neurological Disease
    Asenapine- 13C,d3 (hydrochloride) is the 13C- and deuterium labeled Asenapine (hydrochloride). Asenapine hydrochloride, an antipsychotic, is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and Dopamine (D2, D3, D4) receptor antagonist with Ki values of 0.03-4.0 nM for 5-HT and 1.3, 0.42, 1.1 nM for Dopamine receptor, respectively.
    Asenapine-13C,d3 hydrochloride
  • HY-118010

    (±)-Norfenfluramine

    Serotonin Transporter Neurological Disease
    Norfenfluramine ((±)-Norfenfluramine) is a major and brain-penetrant metabolite of Fenfluramine. Norfenfluramine can interact with 5-HT transporters to release 5-HT from neurons. Norfenfluramine displays antiepileptic effects in vivo [1] .
    Norfenfluramine
  • HY-B0002BS1

    GR 38032-d<sub>3sub>; SN 307-d<sub>3sub>

    5-HT Receptor Isotope-Labeled Compounds Neurological Disease
    Ondansetron-d3 is the deuterium labeled Ondansetron (HY-B0002B ). Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist with an IC50 value of 103 pM. Ondansetron exerts its antiemetic effect by antagonizing 5-HT receptors located in localized neurons in the peripheral and central nervous systems. Ondansetron can inhibit nausea and vomiting induced by chemotherapy and radiotherapy [1] [5] .
    Ondansetron-d3
  • HY-B0002BS

    GR 38032-d<sub>5sub>; SN 307-d<sub>5sub>

    5-HT Receptor Isotope-Labeled Compounds Neurological Disease
    Ondansetron-d5 is the deuterium labeled Ondansetron (HY-B0002B). Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist with an IC50 value of 103 pM. Ondansetron exerts its antiemetic effect by antagonizing 5-HT receptors located in localized neurons in the peripheral and central nervous systems. Ondansetron can inhibit nausea and vomiting induced by chemotherapy and radiotherapy [1] [5] .
    Ondansetron-d5
  • HY-103156

    5-HT Receptor Neurological Disease
    NAS181 is a potent and selective antagonist of rat 5-HT1B receptor, with a Ki of 47 nM. NAS181 shows 13-fold selectivity for r5-HT1B over bovine 5-HT1B receptor (Ki=630 nM). NAS181 increases the 5-HT turnover and the synaptic concentration of 5-HT by inhibiting terminal r5-HT1B autoreceptors [1] .
    NAS-181 dimesylate
  • HY-101456
    PCPA methyl ester hydrochloride
    3 Publications Verification

    4-Chloro-DL-phenylalanine methyl ester hydrochloride

    Tryptophan Hydroxylase 5-HT Receptor Neurological Disease
    PCPA methyl ester hydrochloride (4-Chloro-DL-phenylalanine methyl ester hydrochloride), a reversible tryptophan hydroxylase inhibitor, is a serotonin (5-HT) synthesis inhibitor. PCPA methyl ester hydrochloride crosses the blood brain barrier and reduces 5-HT central availability [1] .
    PCPA methyl ester hydrochloride
  • HY-101344

    5-HT Receptor Neurological Disease
    Cyanopindolol fumarate is a 5-HT receptor antagonist [1].
    Cyanopindolol fumarate
  • HY-B0457S2

    Chlorimipramine-13C,d<sub>3sub> hydrochloride; G-34586-13C,d<sub>3sub> hydrochloride; NSC-169865-13C,d<sub>3sub> hydrochloride

    Isotope-Labeled Compounds Serotonin Transporter Neurological Disease
    Clomipramine- 13C,d3 (hydrochloride) is the 13C- and deuterium labeled Clomipramine (hydrochloride). Clomipramine (Chlorimipramine) hydrochloride is a potent 5-HT reuptake blocker with the IC50 value of 1.5 nM. Clomipramine hydrochloride is a tricyclic antidepressant that can be used for the research of depression and obsessive compulsive disorder (OCD) [1].
    Clomipramine-13C,d3 hydrochloride
  • HY-135507A

    5-HT Receptor Neurological Disease
    NAS181 free base is a potent and selective antagonist of rat 5-HT1B receptor, with a Ki of 47 nM. NAS181 free base shows 13-fold selectivity for r5-HT1B over bovine 5-HT1B receptor (Ki=630 nM). NAS181 free base increases the 5-HT turnover and the synaptic concentration of 5-HT by inhibiting terminal r5-HT1B autoreceptors [1] .
    NAS-181 free base
  • HY-W015169S

    O-Methylserotonin-d<sub>4sub>

    Isotope-Labeled Compounds 5-HT Receptor Drug Metabolite Neurological Disease Cancer
    5-Methoxytryptamine-d4 (O-Methylserotonin-d4) is the deuterium labeled 5-Methoxytryptamine (HY-W015169). 5-Methoxytryptamine, a metabolite of Melatonin, is a nonselective 5-HT receptor agonist. 5-Methoxytryptamine has no affinity for the 5-HT3 receptor. 5-Methoxytryptamine is also a potent antioxidant and has radioprotective action [1] .
    5-Methoxytryptamine-d4
  • HY-14544AS

    ICI204636-d<sub>4sub> hydrochloride

    Isotope-Labeled Compounds Dopamine Receptor 5-HT Receptor Neurological Disease
    Quetiapine-d4 (hydrochloride) (ICI204636-d4 (hydrochloride)) is deuterium labeled Quetiapine. Quetiapine (ICI204636) is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor. Quetiapine is a dopamine receptor antagonist with a pIC50 of 6.33 for human D2 receptor. Quetiapine has moderate to high affinity for the human D2, HT1A, 5-HT2A, 5-HT2C receptor with pKis of 7.25, 5.74, 7.54, 5.55. Antidepressant and anxiolytic effects [1] .
    Quetiapine-d4 hydrochloride
  • HY-172978

    5-HT Receptor Neurological Disease
    5-HT2A receptor agonist-8 (compound 8) is a potent 5-HT2A receptor agonist with an EC50 of 0.6784 nM. 5-HT2A receptor agonist-8 can be used in the study of depressive disorders and bipolar disorders [1].
    5-HT2A receptor agonist-8
  • HY-103089

    5-HT Receptor Neurological Disease
    LY393558 is a potent and orally active inhibitor of the 5-HT transporter and an antagonist of 5-HT1B and 5-HT1D receptors. LY393558 increase the extracellular levels of 5-HT in mice model frontal cortex. LY393558 can be used for researching depression [1].
    LY393558
  • HY-A0095S1

    BIMT-17-d<sub>4sub>-1; BIMT-17BS-d<sub>4sub>-1

    Isotope-Labeled Compounds 5-HT Receptor Neurological Disease
    Flibanserin-d4-1 is deuterium labeled Flibanserin. Flibanserin (BIMT-17) is a full agonist of the serotonin 5-HT1A receptor (Ki=1 nM) and an antagonist of 5-HT2A (49 nM). Flibanserin binds to dopamine D4 receptors (4-24 nM), and has negligible affinity for a variety of other neurotransmitter receptors and ion channels. Flibanserin is efficacious in treating hypoactive sexual desire disorder (HSDD) [1] .
    Flibanserin-d4-1
  • HY-B1287
    Citalopram hydrobromide
    5+ Cited Publications

    (±)-Citalopram hydrobromide; Lu 10-171

    Serotonin Transporter Autophagy Neurological Disease Cancer
    Citalopram hydrobromide is a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide inhibits 5-HT uptake into synaptosomes with an IC50 of 1.8 nM. Citalopram hydrobromideinhibits the 5-HT uptake in rabbit blood platelets with an IC50 of 14 nM. Antidepressant effect [1].
    Citalopram hydrobromide
  • HY-107370S

    Tomoxetine-d<sub>7sub>; (R)-Tomoxetine-d<sub>7sub>

    Isotope-Labeled Compounds Serotonin Transporter Sodium Channel Neurological Disease Cancer
    Atomoxetine-d7 (Tomoxetine-d7) is deuterium labeled Atomoxetine. Atomoxetine (Tomoxetine) is a selective noradrenaline reuptake inhibitor with Ki values of 5, 77 and 1451 nM for norepinephrine (NE), serotonin (5-HT) and dopamine (DA) transporters, respectively. Atomoxetine (Tomoxetine) increases of DAEX and NEEX in the PFC and enhances catecholaminergic neurotransmission. Atomoxetine (Tomoxetine) is a potent Na + channels (VGSCs) blocker. Atomoxetine (Tomoxetine) can be used for attention-deficit hyperactivity disorder (ADHD) research [1] .
    Atomoxetine-d7
  • HY-107370S1

    Tomoxetine-d<sub>5sub>; (R)-Tomoxetine-d<sub>5sub>

    Isotope-Labeled Compounds Neurological Disease Cancer
    Atomoxetine-d5 (Tomoxetine-d5) is deuterium labeled Atomoxetine. Atomoxetine (Tomoxetine) is a selective noradrenaline reuptake inhibitor with Ki values of 5, 77 and 1451 nM for norepinephrine (NE), serotonin (5-HT) and dopamine (DA) transporters, respectively. Atomoxetine (Tomoxetine) increases of DAEX and NEEX in the PFC and enhances catecholaminergic neurotransmission. Atomoxetine (Tomoxetine) is a potent Na + channels (VGSCs) blocker. Atomoxetine (Tomoxetine) can be used for attention-deficit hyperactivity disorder (ADHD) research [1] .
    Atomoxetine-d5
  • HY-B0002BS2

    GR 38032-13C,d<sub>3sub>; SN 307-13C,d<sub>3sub>

    Isotope-Labeled Compounds 5-HT Receptor Neurological Disease
    Ondansetron- 13C,d3 is the 13C- and deuterium labeled Ondansetron (HY-B0002B). Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist with an IC50 value of 103 pM. Ondansetron exerts its antiemetic effect by antagonizing 5-HT receptors located in localized neurons in the peripheral and central nervous systems. Ondansetron can inhibit nausea and vomiting induced by chemotherapy and radiotherapy [1] [5] .
    Ondansetron-13C,d3
  • HY-W380450

    Viloxazin; Emovit

    5-HT Receptor Neurological Disease
    Viloxazine is a non-brain-penetrant, selective norepinephrine transporter (NET) inhibitor (IC50= 0.26 μM) and 5-HT receptor modulator. Viloxazine antagonizes 5-HT2B receptors (Ki=4.2 μM) and agonizes 5-HT2C receptors (EC50= 32 μM), respectively, and enhances 5-HT neurotransmission by modulating 5-HT2B/C receptors. Viloxazine also competitively inhibits NET from increasing NE and DA levels in the synaptic cleft, and can be used in the study of attention deficit hyperactivity disorder (ADHD) [1] .
    Viloxazine
  • HY-101630A

    EGIS-3886 fumarate

    5-HT Receptor Others
    Deramciclane fumarate is an antagonist of 5-HT Receptor. Deramciclane fumarate is an inverse agonist of 5-HT2C Receptor with an IC50 of 168 nM. Deramciclane fumarate also decreases basal phosphoinositide hydrolysis [1] .
    Deramciclane fumarate
  • HY-B1110S

    (±)-Nomifensine-d<sub>3sub> maleate; Nomifensin-d<sub>3sub> maleate

    Isotope-Labeled Compounds Dopamine Receptor Adrenergic Receptor Neurological Disease
    Nomifensine-d3 ((±)-Nomifensine-d3) maleate is the deuterium labeled Nomifensine maleate (HY-B1110A). Nomifensine ((±)-Nomifensine) maleate is a potent norepinephrine (NE) and dopamine (DA) reuptake inhibitor. Nomifensine maleate inhibits uptake of NE, DA and 5-HT in rat brain synaptosomes, with IC50 values of 6.6 nM, 48 nM and 830 nM, and Ki values of 4.7 nM, 26 nM and 4000 nM, respectively. Nomifensine maleate has antidepressant and analgesic effects. Nomifensine maleate is used in neurodegenerative diseases, compound addiction, and pain research [1] [5] .
    Nomifensine-d3 maleate
  • HY-159492

    5-HT Receptor Neurological Disease
    5-HT7 receptor ligand 2 (compound 32) is an arylpiperazinehydrazine ligand for 5-HT7R (Ki=178 nM). 5-HT7 receptor ligand 2 has good membrane permeability, low hepatotoxicity and cardiotoxicity, and high plasma protein binding. 5-HT7 receptor ligand 2 shows neuroprotective effects in SH-SY5Y cells and can be used for the study of central nervous system related diseases [1].
    5-HT7 receptor ligand 2
  • HY-125784

    Viloxazin hydrochloride; Emovit hydrochloride

    5-HT Receptor Neurological Disease
    Viloxazine hydrochloride is a non-brain-penetrant, selective norepinephrine transporter (NET) inhibitor (IC50=0.26 μM) and 5-HT receptor modulator. Viloxazine antagonizes 5-HT2B receptors (Ki=4.2 μM) and agonizes 5-HT2C receptors (EC50=32 μM), respectively, and enhances 5-HT neurotransmission by modulating 5-HT2B/C receptors. Viloxazine also competitively inhibits NET from increasing NE and DA levels in the synaptic cleft, and can be used in the study of attention deficit hyperactivity disorder (ADHD) [1] .
    Viloxazine hydrochloride
  • HY-17032A

    (rac)-AS1069562 hydrochloride; YM-08054

    5-HT Receptor Neurological Disease
    Indeloxazine hydrochloride is a 5-HT receptor and norepinephrine (NE) reuptake inhibitor. Indeloxazine hydrochloride is an antidepressant and cerebral activator [1].
    Indeloxazine hydrochloride

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: